507 Evaluation of patients with progressive metastatic head and neck cancer treated with PD-1 inhibition with Pembrolizumab and radiation therapy: Assessment of local and systemic effects. (September 2015) - Das, L.C.; Haraf, D.; Brisson, R.; McHugh, M.; Cheng, J.; Heath, K.; Villaflor, V.; Vokes, E.E.; Weichselbaum, R.R.; Seiwert, T.Y.